Dergiler / The Anatolian Journal of Cardiology / 2018 / Cilt: 19 - Sayı: 5

Catalpol pretreatment attenuates cardiac dysfunction following myocardial infarction in rats

Sayfa
296–302
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Its protective effects may be linked to the enhancement of myocardiumcontractility, regulation of the apelin/APJ pathway, and inhibition of cardiomyocyte apoptosis.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objective: To investigate the effects and mechanisms of catalpol on cardiac function in rats with isoproterenol (ISO)-induced myocardial infarction(MI).Methods: Adult male Wistar rats were divided into four groups: control group, ISO group, catalpol (L, low dose) group, and catalpol (H, high dose)group.
📊
Temel Bulgular & Veri:Isoproterenol (85 mg/kg) was injected subcutaneously for 2 consecutive days to induce experimental MI.
💡
Sonuç & Katkı:Its protective effects may be linked to the enhancement of myocardiumcontractility, regulation of the apelin/APJ pathway, and inhibition of cardiomyocyte apoptosis.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Objective: To investigate the effects and mechanisms of catalpol on cardiac function in rats with isoproterenol (ISO)-induced myocardial infarction(MI).Methods: Adult male Wistar rats were divided into four groups: control group, ISO group, catalpol (L, low dose) group, and catalpol (H, high dose)group. Isoproterenol (85 mg/kg) was injected subcutaneously for 2 consecutive days to induce experimental MI. At the end of experiment, theeffects of catalpol on cardiac function; apelin levels; apoptosis index; apelin, APJ, Bcl-2, and Bax protein expression; and caspase-3/9 activitieswere investigated.Results: The rats in the ISO group showed lower left ventricular maximum rate of positive or negative pressure development (±LVdp/dtmax) andleft ventricular end-systolic pressure (LVSP) and higher left ventricular end-diastolic pressure (LVEDP) than those in the control group, suggestingsevere cardiac dysfunction. Interestingly, catalpol administration significantly ameliorated the ISO-induced cardiac dysfunction. The groupsadministered low and high dosages catalpol (5 and 10 mg/kg/day, respectively) showed higher ±LVdp/dtmax and LVSP and lower LVEDP than thegroup administered ISO alone. Catalpol markedly upregulated apelin levels in the plasma and myocardium. Further, catalpol increased the apelinand APJ expression levels in the myocardium of the ISO-treated rats. In addition, catalpol pretreatment inhibited cardiomyocyte apoptosis asindicated by a decrease in the TUNEL-positive cell percentage, alterations in the Bax and Bcl-2 expression levels, and a decline in caspase-3and caspase-9 activities.Conclusion: Our results revealed that catalpol can improve cardiac function. Its protective effects may be linked to the enhancement of myocardiumcontractility, regulation of the apelin/APJ pathway, and inhibition of cardiomyocyte apoptosis.

🔖

Bu Makaleye Atıf Yap

Bİ, F., XU, Y., SUN, Q. (2018). Catalpol pretreatment attenuates cardiac dysfunction following myocardial infarction in rats. The Anatolian Journal of Cardiology, Cilt: 19 - Sayı: 5, 296–302. https://ajindex.com/articles/365256

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (2)

  1. Cory S, Adams JM. The Bcl2 family: regulators of the cellular life-ordeath switch. Nat Rev Cancer 2002; 2: 647-56. [CrossRef] Brunelle JK, Letai A. Control of mitochondrial apoptosis by the Bcl-2 family. J Cell Sci 2009; 122(Pt 4): 437-41. [CrossRef] Wei MC, Zong WX, Cheng EH, Lindsten T, Panoutsakopoulou V, Ross AJ, et al. Proapoptotic BAX and BAK: A requisite gateway to mitochondrial dysfunction and death. Science 2001; 292: 727-30. [CrossRef] Kirkland RA, Franklin JL. Bax, reactive oxygen, and cytochrome c release in neuronal apoptosis. Antioxid Redox Signal 2003; 5: 589-96.
  2. Soga M, Kamal FA, Watanabe K, Ma M, Palaniyandi S, Prakash P, et al. Effects of angiotensin II receptor blocker (candesartan) in daunorubicin-induced cardiomyopathic rats. Int J Cardiol 2006; 110: 378-85. [CrossRef] Ahmet I, Krawczyk M, Heller P, Moon C, Lakatta EG, Talan MI. Beneficial effects of chronic pharmacological manipulation of betaadrenoreceptor subtype signaling in rodent dilated ischemic cardiomyopathy. Circulation 2004; 110: 1083-90. [CrossRef] Abbate A, Biondi-Zoccai GG, Bussani R, Dobrina A, Camilot D, Feroce F, et al. Increased myocardial apoptosis in patients with unfavorable left ventricular remodeling and early symptomatic postinfarction heart failure. J Am Coll Cardiol 2003; 41: 753-60. [CrossRef] Yang B, Ye D, Wang Y. Caspase-3 as a therapeutic target for heart failure. Expert Opin Ther Targets 2013; 17: 255-63. [CrossRef] Wang X, Wang Q, Guo W, Zhu YZ. Hydrogen sulfide attenuates cardiac dysfunction in a rat model of heart failure: a mechanism through cardiac mitochondrial protection. Biosci Rep 2011; 31: 87-98. [CrossRef] Kuba K, Zhang L, Imai Y, Arab S, Chen M, Maekawa Y, et al. Impaired heart contractility in Apelin gene-deficient mice associated with aging and pressure overload. Circ Res 2007; 101: e32–42. [CrossRef] Berry MF, Pirolli TJ, Jayasankar V, Burdick J, Morine KJ, Gardner T, et al. Apelin has in vivo inotropic effects on normal and failing hearts. Circulation 2004; 110(11 Suppl 1): II187-93. [CrossRef] Medhurst AD, Jennings CA, Robbins MJ, Davis RP, Ellis C, Winborn KY, et al. Pharmacological and immunohistochemical characterization of the APJ receptor and its endogenous ligand apelin. J Neurochem 2003; 84: 1162-72. [CrossRef] Boucher J, Masri B, Daviaud D, Gesta S, Guigne C, Mazzucotelli A, et al. Apelin, a newly identified adipokine up-regulated by insulin and obesity. Endocrinology 2005; 146: 1764-71. [CrossRef] Xu W, Yang J, Wu LM. Cardioprote